APBB1 and Alzheimer disease: Indeed, despite all these aspects deserving further investigation, our findings suggest a crucial upstream role for Fyn and Fe65 and their clinical relevance as a possible pharmacological target in controlling APP Tyr682 phosphorylation and thus preventing Aβ42 increase in AD neurons.